Patient monitoring devices supplier LiDCO increased its product revenues by 10% in the year to July 2019.
Even so, there has also been success in building up SaaS-based high usage programme revenues. The annualised value is £2.1m. There is potential to add to that in the second half, particularly in the US.
Interim revenues fell 4% to £3.5m, but that was due to the loss of a third-party distribution contract. The loss has been reduced and it could halve to £1m for the full year. LiDCO should still have net cash of £1.2m at the end of January 2020.
© 2020 Aim Micro. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.